AUA
  • Meeting Coverage
  • Program
  • Industry Highlights
  • Science & Technology Hall
Topics
  • Meeting Coverage
  • Program
  • Industry Highlights
  • Science & Technology Hall
Twitter iconFacebook iconInstagram iconYouTube iconLinkedIn icon
May 14, 2022

Crossfire: To test or not to test

Urologists debate the value of stone analysis and metabolic urine testing for their patients.


Kymora Scotland, MD, PhD, and Justin Friedlander, MD
Kymora Scotland, MD, PhD, and Justin Friedlander, MD

Do urologists really need stone analysis and metabolic urine testing? That was the question posed at Saturday afternoon’s Crossfire: Controversies in Urology Debate: “Do We Really Need Stone Analysis and Metabolic Urine Testing?”

Moderated by Glenn M. Preminger, MD, professor of urologic surgery at Duke University Hospital in Durham, North Carolina, the Crossfire session teamed “Yea” panelists Justin Friedlander, MD, and Sara Best, MD, against the “Nay” team of Kymora Scotland, MD, PhD, and Ryan Hsi, MD.

Dr. Friedlander, director of endoscopic urologic surgery and the Comprehensive Kidney Stone Center at Albert Einstein Medical Center in Philadelphia, Pennsylvania, came out swinging, saying that yes, stone analysis and metabolic testing are needed for several reasons.

“It helps make the diagnosis; it helps reduce recurrence; it is cost-effective for our recurrent stone formers; and it helps with compliance and management,” Dr. Friedlander said. “It is also supported by the AUA guidelines and it gives hope to lifelong disease.”

The AUA’s current medical management guidelines include the following statements:

  • When a stone is available, clinicians should obtain a stone analysis at least once. (Clinical Principle)
  • Metabolic testing should consist of one or two 24-hour urine collections obtained on a random diet and analyzed at minimum for total volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium and creatinine. (Expert Opinion)

Dr. Scotland, assistant professor and endourologist at UCLA in Los Angeles, California, conceded that stone analysis and metabolic testing are guideline-supported items; provide patients with quantifiable targets; help with screening for rarer diseases like cystinuria and primary hypoxia; help noninvasively track patient compliance with fluids and medications; and give hope to patients who have a lifelong disease.

“But let's not forget the actual endpoint here,” Dr. Scotland said. “[It] should be stone recurrence. There is no reason to do all of this if there is no effect on stone recurrence.

“It is my position that stone analysis and metabolic testing provide limited utility for most stone formers. [The tests] do not predict recurrence. They do not prevent recurrence, and they may, in fact, increase cost.”

In her rebuttal statement, Dr. Best, an associate professor of urology at the University of Wisconsin School of Medicine and Public Health in Madison, said the tests allow for cost-effective precision medicine, improve patient buy-in and maximize patient outcomes.

Dr. Hsi, an associate professor of urology at Vanderbilt University Medical Center in Nashville, Tennessee, countered by positing that the tests are challenging to interpret, uncommonly performed and impractical in certain clinical scenarios.

Interesting Stories
Read All About It
Sponsored by AUA
Read All About It
More Content
Gregory Broderick, MD
Meeting Coverage
The internet and healthy sexuality: Friend or foe?
May 24, 2022
Cme
Meeting Coverage
Claim your CME
May 24, 2022
Au Anav
Meeting Coverage
AUA2022 On Demand
May 24, 2022
Screen Shot 2022 05 23 At 4 21 31 Pm
Meeting Coverage
Must-see TV
May 24, 2022
Getty Images 1300068435
Meeting Coverage
Save the date!
May 24, 2022
Covers
Meeting Coverage
Read all about it
May 24, 2022
AUA President Raju Thomas
Meeting Coverage
AUA President Raju Thomas addresses his past year leading the Association
May 18, 2022
Kymora Scotland, MD, PhD, and Justin Friedlander, MD
Meeting Coverage
Up for debate
May 18, 2022
James A. Eastham, MD, FACS
Meeting Coverage
Guideline updates
May 18, 2022
Glenn M. Preminger, MD
Meeting Coverage
Award winners
May 18, 2022
Surgery
Meeting Coverage
New technology
May 18, 2022
From left: Michael A. Rees, MD, PhD; Alp Sener, MD, PhD, FRCSC; and Jeffrey Lorne Veale, MD
Meeting Coverage
Panel discussions
May 18, 2022
AUA
Twitter iconFacebook iconInstagram iconYouTube iconLinkedIn icon
© 2023 Ascend Media. All rights reserved.